Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Definium Therapeutics, Inc. (DFTX) News - StockMarketCap

Stocks›Definium Therapeutics, Inc.☆

● At closeAs of Jul 2, 2026

Definium Therapeutics, Inc.

DFTX✓

HealthcareBiotechnologyNASDAQ

$44.19+1.82%

$4.82BMarket cap

-P/E ratio

2.34MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$44.19

$0.79 (+1.82%) · 24h

Key metrics

Market cap$4.82B+95.51%

Enterprise value$4.82B

Volume (24h)2.34M

P/E ratio (TTM)-

P/S ratio (TTM)-

Dividend yield-

Shares outstanding109.07M

Trading range

Previous close$43.40

Day range$42.42 - $44.49

52-week range-

Definium Therapeutics, Inc. (DFTX) operates in the Biotechnology industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news